P14.122 Integrin α5 is a poor prognostic factor in patients with glioblastoma treated by the Stupp protocol

BACKGROUND: Integrin α5β1 was suggested to be involved in glioblastoma (GBM) aggressiveness through preclinical studies and genomic analysis of several cohorts of patients. However, protein expression data are still missing to confirm this hypothesis. Our aim was to investigate the prognostic value...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Etienne-Selloum, N, Prades, J, Bello Roufai, D, El Azumi, F, Boone, M, Sevestre, H, Trudel, S, Coutte, A, Desenclos, C, Constans, J, Chauffert, B, Dontenwill, M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795171/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.357
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados